Amgen Inc.

NASDAQ Global Select
Back to all articles
Slightly Bullish +15

Forum Financial Management LP Sells 2,792 Shares of Amgen Inc. $AMGN - MarketBeat

AI-generated analysis

📉 Forum Financial Management LP trimmed its Amgen position by 0.8%, selling 2,792 shares to end the quarter with a $122.4 million stake.

📈 Major institutional investors including Norges Bank, Capital World Investors, and State Street Corp significantly increased their holdings in Q4.

💰 Amgen beat quarterly EPS estimates of $4.77 with actual results of $5.15 and revenue of $8.62 billion.

📊 The company reported a net margin of 20.96% and achieved 5.8% year-over-year revenue growth.

🎯 Analyst consensus remains 'Hold' with a price target of $354.42, though targets vary from $332 to $410 across different firms.

👤 SVP Nancy A. Grygiel sold 1,237 shares in May, reducing her personal holding by 15% for a total value of roughly $400k.

📅 Amgen provided FY 2026 guidance expecting EPS between $21.70 and $23.10.

🏢 Institutional ownership stands at 76.5%, with the top holders collectively owning over $25 billion in stock.

Bullish Signals
  • Amgen beat quarterly earnings per share estimates by $0.38, reporting $5.15 EPS against a consensus of $4.77.
  • The company exceeded revenue expectations with $8.62 billion reported versus an analyst estimate of $8.58 billion.
  • Net margin remained robust at 20.96%, demonstrating strong profitability on the generated revenue.
  • Major institutional investors like Capital World Investors and State Street Corp increased their stakes significantly in Q4.
  • The company achieved a high return on equity of 137.41% for the quarter.
  • Revenue grew by 5.8% year-over-year, indicating continued top-line expansion.
Risk Factors
  • Forum Financial Management LP reduced its stake in Amgen by 0.8% during the first quarter.
  • Analyst consensus rating is 'Hold' with a target price of $354.42, suggesting limited immediate upside according to Wall Street averages.
  • Daiwa Securities Group lowered its price objective from $410.00 to $390.00 in recent research.
  • SVP Nancy A. Grygiel sold 1,237 shares of stock in May, reducing her personal position by 15%.
Full Analysis
Forum Financial Management LP reduced its stake in Amgen Inc. (AMGN) by selling 2,792 shares during the first quarter, representing a 0.8% trim of its position. The firm now holds approximately 347,970 shares valued at $122.4 million, which constitutes about 1.7% of its total portfolio and ranks as its 11th largest holding. Despite the institutional sell-off by Forum Financial Management LP, major investors like Norges Bank, Capital World Investors, State Street Corp, Geode Capital Management LLC, and Amundi significantly increased their holdings in the fourth quarter. Collectively, these institutions own 76.5% of the company's outstanding stock, indicating strong continued interest from large-scale asset managers. Amgen reported strong quarterly financial results for the period ending April 30th, beating analyst estimates with earnings per share (EPS) of $5.15 versus a consensus of $4.77 and revenue of $8.62 billion against an estimate of $8.58 billion. The company achieved a net margin of 20.96% and reported year-over-year revenue growth of 5.8%, while setting forward guidance for FY 2026 EPS between $21.70 and $23.10. Analyst sentiment regarding AMGN remains mixed, with a consensus rating of 'Hold' and a target price of $354.42. While some firms like Morgan Stanley raised their price targets, others such as Daiwa Securities lowered theirs. Insider trading activity saw SVP Nancy A. Grygiel sell 1,237 shares in May, reducing her personal stake by 15%.